SEC 13F Intelligence

C Worldwide Group Holding A/S / SRPT

C Worldwide Group Holding A/S’s Sarepta Therapeutics Inc Position

Does C Worldwide Group Holding A/S own Sarepta Therapeutics Inc (SRPT)? Yes — 490.3K shares worth $11M (+0.23% of its 13F portfolio) as of Q1 2026.

Position Value
$11M
Q1 2026
Shares
490.3K
% of Portfolio
+0.23%
Quarters Held
29
currently held

Position History SRPT

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q2 ’19: $18MQ3 ’19: $11MQ4 ’19: $19MQ1 ’20: $14MQ1 ’20Q2 ’20: $23MQ3 ’20: $20MQ4 ’20: $21MQ1 ’21: $9MQ1 ’21Q2 ’21: $9MQ3 ’21: $11MQ4 ’21: $11MQ1 ’22: $9MQ1 ’22Q2 ’22: $9MQ3 ’22: $13MQ4 ’22: $16MQ1 ’23: $19MQ1 ’23Q2 ’23: $16MQ3 ’23: $17MQ4 ’23: $14MQ1 ’24: $18MQ1 ’24Q2 ’24: $22MQ3 ’24: $18MQ4 ’24: $23MQ1 ’25: $16MQ1 ’25Q2 ’25: $8MQ3 ’25: $9MQ4 ’25: $11MQ1 ’26: $11MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026490.3K$11M+0.23%
Q4 2025490.3K$11M+0.18%
Q3 2025490.3K$9M+0.15%
Q2 2025490.3K$8M+0.11%
Q1 2025250.3K$16M+0.20%
Q4 2024190.3K$23M+0.28%
Q3 2024140.3K$18M+0.18%
Q2 2024140.3K$22M+0.24%
Q1 2024140.3K$18M+0.21%
Q4 2023140.3K$14M+0.18%
Q3 2023140.3K$17M+0.23%
Q2 2023140.3K$16M+0.21%
Q1 2023140.3K$19M+0.26%
Q4 2022120.3K$16M+0.21%
Q3 2022120.3K$13M+0.18%
Q2 2022120.3K$9M+0.11%
Q1 2022120.3K$9M+0.10%
Q4 2021120.3K$11M+0.10%
Q3 2021120.3K$11M+0.11%
Q2 2021120.3K$9M+0.10%
Q1 2021120.3K$9M+0.09%
Q4 2020120.3K$21M+0.21%
Q3 2020145.3K$20M+0.23%
Q2 2020145.3K$23M+0.27%
Q1 2020145.3K$14M+0.20%
Q4 2019145.3K$19M+0.22%
Q3 2019145.3K$11M+0.14%
Q2 2019115.3K$18M+0.22%
Q1 201925.3K$3M+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See C Worldwide Group Holding A/S’s full portfolio or all institutional holders of SRPT.